1. Home
  2. FLOC vs CMPX Comparison

FLOC vs CMPX Comparison

Compare FLOC & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowco Holdings Inc.

FLOC

Flowco Holdings Inc.

HOLD

Current Price

$27.21

Market Cap

944.8M

Sector

Industrials

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.07

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLOC
CMPX
Founded
1996
2014
Country
United States
United States
Employees
1281
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.8M
927.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FLOC
CMPX
Price
$27.21
$2.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$28.50
$14.57
AVG Volume (30 Days)
588.4K
12.1M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
1.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.92
N/A
Revenue Next Year
$8.59
$934.41
P/E Ratio
$16.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.03
$1.61
52 Week High
$28.26
$6.88

Technical Indicators

Market Signals
Indicator
FLOC
CMPX
Relative Strength Index (RSI) 64.93 34.36
Support Level $14.96 $1.61
Resistance Level N/A $3.54
Average True Range (ATR) 1.08 0.14
MACD 0.09 0.13
Stochastic Oscillator 81.76 78.75

Price Performance

Historical Comparison
FLOC
CMPX

About FLOC Flowco Holdings Inc.

Flowco Holdings Inc is a provider of production optimization, artificial lift, emissions management, and monetization solutions for the oil and natural gas industry. Its technologies include high-pressure gas lift (HPGL), conventional gas lift, plunger lift, and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions, which includes rental services, and Natural Gas Technologies, which include service, gas compression parts, and equipment sales. Production Solutions: relates to rentals, sales, and services related to high-pressure gas lift, conventional gas lift, and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue. It generates maximum revenue from the United States.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: